Website Header with Language Selector and Dropdowns
Image

Isosulfan Blue N-Oxide (Sodium Salt)


Catalog Number: CL-ISB-08
CAS No.: NA
Mol.F: C27H31N2O7S2 : Na
Mol.W: 559.7 : 23.0
Inv. Status: Custom Synthesis

Chemical Name: Sodium 2-((4-(diethyliminio)cyclohexa-2,5-dien-1-ylidene)(4-(diethyloxidoazanyl)phenyl)methyl)benzene-1,4-disulfonate.

Country of Origin: India

Product Category: Isosulfan Blue Impurities


Isosulfan Blue N-Oxide (Sodium Salt) is identified by CAS No. NA and is chemically known as Sodium 2-((4-(diethyliminio)cyclohexa-2,5-dien-1-ylidene)(4-(diethyloxidoazanyl)phenyl)methyl)benzene-1,4-disulfonate.

Isosulfan Blue N-Oxide (Sodium Salt) is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Isosulfan Blue.

Page Keywords: Buy Isosulfan Blue N-Oxide (Sodium Salt) | Purchase Isosulfan Blue N-Oxide (Sodium Salt) | Isosulfan Blue N-Oxide (Sodium Salt) suppliers | Isosulfan Blue N-Oxide (Sodium Salt) manufacturers | Isosulfan Blue N-Oxide (Sodium Salt) price | Isosulfan Blue N-Oxide (Sodium Salt) Importer | Isosulfan Blue N-Oxide (Sodium Salt) Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-ISB-05
CAS No: NA
Mol Wt: 516.6
Mol F: C25H28N2O6S2
Inv. Status: Custom Synthesis
CAT No: CL-ISB-01
CAS No: 68238-36-8
Mol Wt: 544.7 : 23.0
Mol F:  C27H32N2O6S2 : Na
Inv. Status: Custom Synthesis
CAT No: CL-ISB-02
CAS No: NA
Mol Wt: 413.5
Mol F: C17H19NO7S2
Inv. Status: Custom Synthesis
CAT No: CL-ISB-03
CAS No:  911358-03-7
Mol Wt: 546.7
Mol F: C27H34N2O6S2
Inv. Status: Custom Synthesis
CAT No: CL-ISB-07
CAS No: NA
Mol Wt: 429.5
Mol F: C17H19NO8S2
Inv. Status: Custom Synthesis
CAT No: CL-ISB-04
CAS No: NA
Mol Wt: 487.5 : 2(23.0)
Mol F: C23H21NO7S2 : 2(Na)
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.